Release of Hypocretin (orexin) During Waking and Sleep States

Overview

Journal J Neurosci

Specialty Neurology

Date 2002 Jul 5

PMID 12097478

Citations 143

Authors

Lyudmila I Kiyashchenko

Boris Y Mileykovskiy

Nigel Maidment

Hoa A Lam

Ming-Fung Wu

Joshi John

John Peever

Jerome M Siegel

Affiliations

Soon will be listed here.

Abstract

Hypocretin (Hcrt or orexin) somas are located in the hypothalamus and project widely to forebrain and brainstem regions, densely innervating monoaminergic and cholinergic cells. Loss of Hcrt function results in the sleep disorder narcolepsy. However, the normal pattern of Hcrt release across the sleep-wake cycle is unknown. We monitored Hcrt-1 release in the basal forebrain, perifornical hypothalamus, and locus ceruleus (LC) across the sleep-wake cycle using microdialysis in freely moving cats and a sensitive solid phase radioimmunoassay. We found that the peptide concentration in dialysates from the hypothalamus was significantly higher during active waking (AW) than during slow-wave sleep (SWS). Moreover, Hcrt-1 release was significantly higher during rapid eye movement (REM) sleep than during SWS in the hypothalamus and basal forebrain. We did not detect a significant difference in release across sleep-waking states in the LC, perhaps because recovered levels of the peptide were lower at this site. Because there was a trend toward higher levels of Hcrt-1 release during AW compared with quiet waking (QW) in our 10 min dialysis samples, we compared Hcrt-1 levels in CSF in 2 hr AW and QW periods. Hcrt-1 release into CSF was 67% higher during AW than during QW. Elevated levels of Hcrt during REM sleep and AW are consistent with a role for Hcrt in the central programming of motor activity.

Citing Articles

Opioid-induced neuroanatomical, microglial and behavioral changes are blocked by suvorexant without diminishing opioid analgesia.

McGregor R, Wu M, Thannickal T, Li S, Siegel J Nat Ment Health. 2025; 2(9):1018-1031.

PMID: 39989723 PMC: 11845277. DOI: 10.1038/s44220-024-00278-2.

Orexin Neurons to Sublaterodorsal Tegmental Nucleus Pathway Prevents Sleep Onset REM Sleep-Like Behavior by Relieving the REM Sleep Pressure.

Feng H, Qiao Q, Luo Q, Zhou J, Lei F, Chen Y Research (Wash D C). 2024; 7:0355.

PMID: 38694202 PMC: 11062508. DOI: 10.34133/research.0355.

Orexins and primary headaches: an overview of the neurobiology and clinical impact.

Stanyer E, Hoffmann J, Holland P Expert Rev Neurother. 2024; 24(5):487-496.

PMID: 38517280 PMC: 11034548. DOI: 10.1080/14737175.2024.2328728.

Orexin and MCH neurons: regulators of sleep and metabolism.

Bouaouda H, Jha P Front Neurosci. 2023; 17:1230428.

PMID: 37674517 PMC: 10478345. DOI: 10.3389/fnins.2023.1230428.

A novel machine learning system for identifying sleep-wake states in mice.

Fraigne J, Wang J, Lee H, Luke R, Pintwala S, Peever J Sleep. 2023; 46(6).

PMID: 37021715 PMC: 10262194. DOI: 10.1093/sleep/zsad101.

References

Nitz D, Siegel J . GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol. 1997; 273(1 Pt 2):R451-5. PMC: 8855516. DOI: 10.1152/ajpregu.1997.273.1.R451. View

Siegel J, Nienhuis R, Fahringer H, Paul R, Shiromani P, Dement W . Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science. 1991; 252(5010):1315-8. PMC: 8784798. DOI: 10.1126/science.1925546. View

Offenbacher M, Stucki G . Physical therapy in the treatment of fibromyalgia. Scand J Rheumatol Suppl. 2000; 113:78-85. DOI: 10.1080/030097400446706. View

Nitz D, Siegel J . GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience. 1997; 78(3):795-801. PMC: 8852367. DOI: 10.1016/s0306-4522(96)00549-0. View

Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y . A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000; 6(9):991-7. DOI: 10.1038/79690. View

Nitz D, Siegel J . GABA release in posterior hypothalamus across sleep-wake cycle. Am J Physiol. 1996; 271(6 Pt 2):R1707-12. PMC: 9050243. DOI: 10.1152/ajpregu.1996.271.6.R1707. View

Thannickal T, Moore R, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M . Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000; 27(3):469-74. PMC: 8760623. DOI: 10.1016/s0896-6273(00)00058-1. View

Kiyashchenko L, Mileykovskiy B, Lai Y, Siegel J . Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J Neurophysiol. 2001; 85(5):2008-16. PMC: 8792979. DOI: 10.1152/jn.2001.85.5.2008. View

Estabrooke I, McCarthy M, Ko E, Chou T, Chemelli R, Yanagisawa M . Fos expression in orexin neurons varies with behavioral state. J Neurosci. 2001; 21(5):1656-62. PMC: 6762959. View

10.

Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X . The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999; 98(3):365-76. DOI: 10.1016/s0092-8674(00)81965-0. View

11.

Hagan J, Leslie R, Patel S, Evans M, Wattam T, Holmes S . Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A. 1999; 96(19):10911-6. PMC: 17982. DOI: 10.1073/pnas.96.19.10911. View

12.

Gerashchenko D, Kohls M, Greco M, Waleh N, Salin-Pascual R, Kilduff T . Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci. 2001; 21(18):7273-83. PMC: 6762996. View

13.

van den Pol A, Gao X, Obrietan K, Kilduff T, Belousov A . Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci. 1998; 18(19):7962-71. PMC: 6793026. View

14.

Burlet S, Tyler C, Leonard C . Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci. 2002; 22(7):2862-72. PMC: 6758338. DOI: 20026234. View

15.

Kilduff T, Peyron C . The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 2000; 23(8):359-65. DOI: 10.1016/s0166-2236(00)01594-0. View

16.

Kruk B, Chmura J, Krzeminski K, Ziemba A, Nazar K, Pekkarinen H . Influence of caffeine, cold and exercise on multiple choice reaction time. Psychopharmacology (Berl). 2001; 157(2):197-201. DOI: 10.1007/s002130100787. View

17.

de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View

18.

Szymusiak R . Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep. 1995; 18(6):478-500. DOI: 10.1093/sleep/18.6.478. View

19.

Cirelli C, Tononi G . On the functional significance of c-fos induction during the sleep-waking cycle. Sleep. 2000; 23(4):453-69. View

20.

Vuori I, Urponen H, Hasan J, Partinen M . Epidemiology of exercise effects on sleep. Acta Physiol Scand Suppl. 1988; 574:3-7. View